Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes-Reference-Cited by-同舟云学术

Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes

Published:2016-09-06 Issue:11 Volume:65 Page:1377-1393
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Gloger Andreas,Ritz Danilo,Fugmann Tim,Neri Dario

Funder

European Commission

European Research Council

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-016-1897-3.pdf

Reference38 articles.

1. Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4):252–264. doi: 10.1038/nrc3239

2. Sharma P, Allison JP (2015) The future of immune checkpoint therapy. Science 348(6230):56–61. doi: 10.1126/science.aaa8172

3. Probst P, Neri D (2014) Immunocytokines for cancer therapy. Forum Immunopathol Dis Therap 5(1):83–99. doi: 10.1615/ForumImmunDisTher.2015014013

4. Kontermann RE, Brinkmann U (2015) Bispecific antibodies. Drug Discov Today 20(7):838–847. doi: 10.1016/j.drudis.2015.02.008

5. Rosenberg SA, Restifo NP (2015) Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348(6230):62–68. doi: 10.1126/science.aaa4967

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer immunopeptidomes contain numerous shared tumor antigens;Journal of Clinical Investigation;2024-01-02

2. TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy;Journal for ImmunoTherapy of Cancer;2023-08

3. Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma;Science Translational Medicine;2023-05-24

4. Soluble HLA peptidome: A new resource for cancer biomarkers;Frontiers in Oncology;2022-12-22

5. MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas;Proceedings of the National Academy of Sciences;2022-12